Results 1 to 10 of about 8,768 (188)
Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia–Reperfusion Injury [PDF]
Objective: This study aimed to investigate the cardioprotective effects of bosentan, an endothelin receptor antagonist, in a rat model of lung ischemia–reperfusion (I/R) injury, with a focus on myocardial tissue involvement.
Şevki Mustafa Demiröz +10 more
doaj +3 more sources
Bosentan Delivery via Nano Metal-Organic Framework nanoMIL-89 Restores Vascular Homeostasis in Pulmonary Arterial Hypertension [PDF]
Mashael A Al-Badr,1,2 Hanan H Abunada,1 Richa Gill,3 Hend S Fayed,4 Ayman Al Haj Zen,4 Mohammad A Al-Ghouti,3 Md Mizanur Rahman,2 Nura A Mohamed,1 Haissam Abou-Saleh5 1Biomedical Research Center, QU Health, Qatar University, Doha, Qatar; 2Biological ...
Al-Badr MA +8 more
doaj +4 more sources
Predicting Systemic and Liver Bosentan Exposure Using Physiologically‐Based Pharmacokinetic Modeling [PDF]
Bosentan is the first approved oral medication for pulmonary arterial hypertension, yet the black‐box warning on its labeling implies a substantial risk of liver injury associated with bosentan exposure.
Miao‐Chan Huang +6 more
doaj +2 more sources
Efficacy and safety of bosentan-related therapy in neonates with persistent pulmonary hypertension of the newborn: a systematic review and meta-analysis [PDF]
ObjectiveTo evaluate the efficacy and safety of bosentan-related therapy in neonates with persistent pulmonary hypertension of the newborn (PPHN).MethodsPubMed, Web of Science, the Cochrane Library, and ClinicalTrials.gov were searched from inception to ...
Guanghong Li +4 more
doaj +2 more sources
In the title compound, C27H29N5O6S·H2O {systematic name: 4-tert-butyl-N-[6-(2-hy-droxy-eth-oxy)-5-(2-meth-oxy-phen-oxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide monohydrate], the dihedral angle between the mean planes of the pyrimidine rings is 27.0 (1)°.
Kaur, Manpreet +6 more
openaire +4 more sources
Introduction Real-world data on the comparative effectiveness of endothelin receptor antagonists (ERAs; macitentan, bosentan, ambrisentan) for pulmonary arterial hypertension (PAH), particularly in Asian countries, are scarce.
Junichi Omura +9 more
doaj +1 more source
D-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension [PDF]
Purpose: Bosentan is a drug currently taken orally for the treatment of pulmonary arterialhypertension. However, the water solubility of bosentan is very low, resulting in lowbioavailability.
Elham Ghasemian +2 more
doaj +1 more source
A GA-guided multidimensional virtual-system coupled molecular dynamics (GA-mD-VcMD) simulation was conducted to elucidate binding mechanisms of a middle-sized flexible molecule, bosentan, to a GPCR protein, human endothelin receptor type B (hETB).
Junichi Higo +10 more
doaj +1 more source
Background/Aims: Both endothelin-1 (ET-1) and the renin-angiotensin system (RAS) may play important roles in renal fibrosis in the obstructed kidney.
Yoon-Kyung Chang +5 more
doaj +1 more source

